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ABSTRACT 
Objective: The purpose of the present investigation was to develop and characterize a novel herbal formulation (polymeric microspheres) of 
Syzygium cumini seed extract.  
Methods: The extract-loaded microspheres using biological macromolecule ethyl cellulose (EC) was prepared by o/w emulsion solvent evaporation 
technique using polyvinyl alcohol (PVA) emulsifier. The effect of various process and formulation variables (stirring speed, evaporation time, 
drug/polymer ratio and organic/aqueous phase ratio) on the properties of microspheres was evaluated.  
Results: Micromeritic properties indicated good flow properties, and scanning electron microscopy (SEM) confirmed the spherical nature of the 
prepared microspheres. The particle size and entrapment efficiency were varied between 34.25 to 176.25 µm and 10.51 to 42% depending upon the 
variables. All the formulations showed minimal drug release in an acidic environment (pH 1.2) confirming the prevention of drug release in the 
stomach and enteric nature of the polymer. Sustained drug release has been observed in alkaline dissolution media (pH 7.4) after 12 h of drug 
release study except for formulation F7 which contains a lower concentration of polymer. The fourier transform infrared spectroscopy (FTIR) 
analysis indicated the compatibility of the extract with the polymer. The absence of extract-polymer interaction was indicated by the differential 
scanning calorimetry (DSC) thermogram. x-ray diffraction (XRD) analysis revealed the amorphous nature of the extract in the microspheres which 
in pure form exhibits a crystalline structure.  
Conclusion: The findings of this present study suggest that microsphere formulation was a promising carrier for novel delivery of herbal drugs. 
Keywords: Polymeric microspheres, Ethylcellulose, Syzygium cumini, Herbal formulation, Solvent evaporation, Polyvinyl alcohol, Phyto-
pharmaceuticals, Novel drug delivery system  




Herbal medicines are the oldest form of health care and the future of 
medicine is rooted in the past. Herbs are staging a comeback and 
herbal “renaissance” is happening all over the globe. People are 
being interested in herbal therapies rather mainstream medicine 
due to there is a growing concern over the reliance and safety of 
drugs and surgery as well as many natural measures produce better 
results than drugs/surgery without the side effects [1]. Diabetes 
mellitus (DM), the third “killer” of mankind, is an important chronic 
metabolic disorder (also called lifestyle disease) affecting 
carbohydrate, protein and fat metabolism. The worldwide survey 
reported that the DM is affecting nearly 10% of the populations. The 
diabetic people are not able to produce or properly use insulin in the 
body, so they have a high level of blood glucose. DM is managed by 
oral hypoglycemic agents which have a characteristic profile of 
serious side effects [2]. So, despite considerable progress in the 
management of DM by synthetic drugs, the search for indigenous 
natural antidiabetic agents is still going on. Ethnobotanical 
information also indicates that more than 800 plants are used as 
traditional remedies for the treatment of diabetes throughout the 
world [3]. Recently herbal medicines have acquired more 
importance in the treatment of diabetes as they are free from side 
effects and less expensive when compared to synthetic 
hypoglycemic agents [4]. Syzygium cumini (L.) seed which is rich in 
polyphenols and flavonoids, has been reported to be widely used as 
the traditional system of medicine to treat diabetes [5]. 
Conventional formulation (powder dosage form) of Syzygium cumini 
seed is available commercially and the diabetic people widely use it 
to regulate their blood glucose level. Drugs of natural origin suffer 
from poor physicochemical properties, which are related to their 
poor bioavailability, diminishing their therapeutic potency despite 
their extraordinary potential [6]. Generally to overcome these 
limitations, developing the novel herbal drug delivery system 
(NHDDS) with better absorption profile is of premier importance 
[1]. These novel formulations are advantageous over conventional 
formulations regarding enhancement of solubility, stability, 
membrane permeability, bioavailability, improved pharmacological 
activity through sustained release profile and reduced toxicity [6]. 
The novel carriers firstly, deliver the drug at a predetermined rate 
over the period of treatment and secondly, channel the active entity 
to the site of action. Whereas the conventional dosage forms are 
unable to achieve these. Micro/nano-sized NHDDS have a potential 
future for enhancing the activity and overcoming problems 
associated with plant medicines [1]. 
In the past, herbal drugs did not attract researcher’s interest in the 
development of NDDS due to difficulties in processing (including 
standardization, extraction, and identification). However, with the 
advancement of modern scientific techniques, recently new doors 
have been opened for the development of novel herbal formulation 
[7]. Today one of the most attractive areas of research in drug 
delivery is the design of polymeric microspheres that are able to 
deliver the drug to the target site, at the right time and right doses 
[8]. Ethyl cellulose is a semi-synthetic, lipophilic, non-toxic, 
biocompatible, non-degradable, cost-effective polymer and has been 
widely used for both lipophilic and hydrophilic drugs in the 
preparation of controlled release dosage form. Among all other 
methods used to prepare microspheres, solvent evaporation 
technique is the simplest one [9].  
No attempts have been made for the development of the novel 
formulation of Syzygium cumini seed extract. In this study, we have 
tried to develop a smart delivery system for the extract. So, the 
objective of the present work was to develop and characterize novel 
herbal formulation (polymeric microspheres) of Syzygium cumini 
seed extract by emulsion solvent evaporation technique using ethyl 
cellulose as the polymer. 
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MATERIALS AND METHODS  
Materials 
Syzygium cumini seed powder (Vyas Pharmaceuticals, a GMP certified 
unit, Indore, MP, India), Ethylcellulose (Loba Chemie Pvt. Ltd.), 
Polyvinyl alcohol (Nice Chemicals P Ltd.), Dichloromethane (Loba 
Chemie Pvt. Ltd.). All other chemicals used were of analytical grade.  
Preparation of extract 
The Syzygium cumini seed powder was extracted with ethanol: 
water (70:30) at room temperature by maceration for 14 d. The 
extract was then filtered and concentrated by a rotary vacuum 
evaporator at a temperature of 400C. It was then kept in the 
refrigerator in an airtight container for further studies. 
Preparation of extract-loaded ethyl cellulose microspheres 
Extract-loaded polymeric microspheres were prepared at room 
temperature by most widely used o/w emulsion solvent evaporation 
technique [10, 11]. Different formulations were prepared by 
dissolving the polymer and drug in dichloromethane (DCM) as 
specified in table 1. This polymeric drug solution (internal oil phase) 
was emulsified by pouring slowly into external aqueous phase 
containing 1% w/v polyvinyl alcohol (PVA) as an emulsifying agent, 
with continuous stirring using propeller type electric stirrer (Remi, 
Mumbai, India). The stirring speed and evaporation time were 
specified in table 1. During the emulsification process, the dispersed 
phase was converted into minute droplets and then solidified into 
rigid microspheres due to evaporation of the organic solvent. The 
resulting microspheres were recovered by filtration, washed three 
times with double distilled water to remove any residual PVA and 
dried at room temperature. All the formulations were prepared in 
triplicate and further characterized. 
Characterization of microspheres 
Production yield 
After drying the obtained microspheres were weighed accurately. 







Table 1: Formulation design of extract-loaded ethyl cellulose microspheres 
Batch code Stirring speed (rpm) Evaporation time (h) Drug/polymer ratio Organic/aqueous phase ratio 
F1 800 3 1:2 1:3 
F2 1000 a 3 1:2 1:3 
F3 1500 3 1:2 1:3 
F4 1000 1 1:2 1:3 
F5 1000 2 1:2 1:3 
F6 1000 a 3 1:2 1:3 
F7 1000 3 1:1 1:3 
F8 1000 a 3 1:2 1:3 
F9 1000 3 1:3 1:3 
F10 1000 a 3 1:2 1:3 
F11 1000 3 1:2 1:5 
F12 1000 3 1:2 1:10 
a
 
Same formulation variables. 
Drug entrapment efficiency (DEE) 
Entrapment efficiency was determined by dissolving 10 mg of 
microspheres in 2 ml DCM. When the particles were completely 
dissolved, the mixture was diluted up to 50 ml with phosphate buffer pH 
7.4 and stirred for 1 h by using a magnetic stirrer for complete removal 
of DCM. The polymer was removed by filtration. The absorbance of the 
filtrate was measured at 760 nm, and the content was determined by 
using a calibration curve of gallic acid, which has been considered as a 







A measured quantity of microspheres was introduced into 10 ml 
measuring cylinder, and the volume was noted. After that, it was tapped 
manually 100 times. Again the volume was noted. The loose and tapped 








Indirect measurement of rheological properties like shape, size, surface 
area, moisture content and cohesiveness of materials is done by using 
















Angle of repose 
The maximum possible angle between the surface of the pile and the 
horizontal plane is known as the angle of repose. It was determined 






h = height of the pile 
r = radius of the pile 
Particle size analysis 
The particle size of the prepared microspheres was measured by the 
optical microscope with the aid of an eye-piece micrometer which 
was previously calibrated with the stage micrometer. The mean 
particle size and size distribution were determined. 
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In vitro drug release studies 
The drug release profile of formulated microspheres was carried out by 
using USP dissolution test apparatus type II rotating paddle. The test was 
performed both in 0.1 N HCl (pH 1.2), and phosphate buffer (pH 7.4) as 
dissolution media (900 ml) maintained at 37±0.5 °C and 100 rpm. The 
samples were withdrawn at predetermined time intervals, filtered and 
analyzed spectrophotometrically at 760 nm. Cumulative % drug release 
(CPR) was calculated from the standard curve. 
Drug-excipients interaction study by FTIR 
The FTIR spectra were taken to investigate the possible interaction 
between drug and polymer in the microspheres formulation. The 
spectra of the extract, polymer, empty microspheres and extract-
loaded microspheres were recorded in the range of 4000-400 cm-1 
from KBr pellet using FTIR (Bruker Alpha T). 
Surface morphology of microspheres (SEM) 
Scanning electron microscopy is an excellent tool to examine the shape 
and surface morphology of the microspheres. Prior to observation, the 
sample was placed on an adhesive stub. The SEM photograph was taken 
at a working distance of 15 mm; the acceleration voltage is 15 kV with 
secondary electron image (SEI) detector. 
X-ray diffraction analysis (XRD) 
The X-RD pattern of the extract and the microspheres were obtained 
by X-ray diffractometer. The samples were irradiated with 
monochromatized X-ray (Cu K∞) with scanning rate of 2 ° min-1in 
the range of 5-70 °C (2Ɵ diffraction angle). The voltage was 40  kV 
and current 30mA. 
Differential scanning calorimetry (DSC) 
Thermal analysis of pure extract and extract-loaded formulation was 
performed with differential scanning calorimeter to determine the 
thermal properties of the drug and that of the formulation. The 
sample was placed into the aluminum container and heated in the 
range of 20-300 °C at a constant rate of 10 °C/min under nitrogen 
atmosphere. 
Drug release kinetics studies  
Drug release mechanism from the microspheres was studied by 
fitting the in vitro release data of optimized formulation to different 
mathematical models such as Zero order (% cumulative drug release 
vs. time), first order (log % drug retained vs. time), Higuchi model 
(% cumulative drug release vs. square root of time) and Peppas 
exponential equation (log % drug release vs. log time). All curve 
fitting, calculation, and plotting were performed using Microsoft 
excel solver, and regression coefficient (R2
RESULTS AND DISCUSSION 
) values were calculated.  
Formulation of microspheres 
The solvent evaporation method, most common and patented, was 
selected for the preparation of ethyl cellulose microspheres for 
novel delivery of Syzygium cumini seed extract. Though the method 
is simple, many factors have been shown to influence the properties 
of the prepared microspheres [12]. Size is one of the most important 
factors that should be considered in the design and development of 
this system as size affects the interaction with the biological system, 
entry of the drug and drug release. Another important parameter is 
the entrapment efficiency (EE) which in turn related to the 
productivity of the pharmaceutical system [13]. The extract loaded 
ethyl cellulose microspheres were prepared successfully by o/w 
emulsion solvent evaporation method. Microspheres were formed 
by pouring a polymeric drug solution in dichloromethane, into the 
aqueous solution of PVA. The evaporation of entrapped 
dichloromethane leads to the formation of microspheres [14]. This 
formed smooth surfaced, spherical shaped microspheres. All the 
batches were prepared according to the formulation design (table 
1). The desirable characteristics of the prepared microspheres are 
high EE, small particle size, and controlled drug release. As various 
formulation and processing variables influenced the properties of 
microspheres, the present work focused towards the systematic 
investigation of the parameters which could influence the 
microspheres characteristics. Gallic acid was used as a marker peak 
for Jamun and its formulations [15]. 
Production Yield 
The percentage yield for all the formulations was found to be in the 
range of 39.53-58.79% (table 2), and it was increasing with 
increased polymer concentration and evaporation time. It decreased 
when the external aqueous phase volume increased. When the 
stirring rate was increased from 800 to 1000 rpm, % yield increased 
(52.23-54.75%), but on further increase in the rate to 1500 rpm, it 
decreased [16, 17]. 
Micromeritic properties 
The micromeritic properties for all the formulations were expressed 
in terms of bulk density, tapped density, Carr’s index, Hausner’s 
ratio and angle of repose. As given in table 2, the values of Carr’s 
index were found to be in the range of 11.3-15.66%, indicating good 
compressibility. Hausner’s ratio was recorded below 1.25, which 
represents good flowability. The angle of repose was found to be 
below 30 °, showing the free-flowing nature of the microspheres. 
The micromeritic properties of all the formulations indicated that 
microspheres were free flowing in nature. The similar finding was 
also reported previously [9, 16]. 
 
Table 2: Production yield and flow properties of extract-loaded ethyl cellulose microspheres 

























































































Data represent mean±standard deviation (SD), n=3. 
 
Drug entrapment efficiency (DEE) 
All the formulations were evaluated for entrapment efficiency (EE), 
and the results are illustrated in table 3, which shows that the 
polymer concentration and evaporation time are directly 
proportional to the EE, whereas the stirring speed and 
organic/aqueous phase volume ratio are inversely proportional to 
the EE [18]. High polymer concentration increases the viscosity of 
the organic phase, which increases the diffusional resistance to the 
drug molecules, thereby reducing the partitioning of the drug into 
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external aqueous phase and entrapping more drug in polymeric 
microspheres [12]. In another way, with the increase in polymer 
concentration, the particle size increases. This causes the decrease 
in the surface area to be exposed to water. Thus, the drug loss due to 
diffusion is reduced and enhanced entrapment [13]. As the drug: 
polymer ratio increased from 1:1 to 1:2 and 1:3. The mean EE 
increased from 18% to 30.03% and 42% respectively.  
Evaporation of organic solvent for the shorter period of time causes 
rapid replacement of the organic solvent with the aqueous medium 
before the droplet hardening occurs. This results in reduced drug 
entrapment. The lowest entrapment (15.01%) was observed when 
the evaporation time was 1h. Upon increasing the aqueous phase 
volume, more amount of drug is dissolved in the aqueous medium. 
Therefore, increasing the drug loss from organic phase results in the 
reduction of the EE [19]. Increased stirring speed delivers greater 
energy to the system, resulting in the faster breakdown of the 
formed microparticles and lowers the drug entrapment [20]. 
Particle size 
The particle size was determined by optical microscopy using 
eyepiece micrometer which was previously calibrated with the stage 
micrometer. The particle size was measured in the range of 34.25-
176.25 µm among different formulations. The mean particle size of 
the microspheres significantly increased (34.25 to 114.75 µm) with 
an increase in polymer concentration. Higher polymer concentration 
with the fixed volume of organic solvent causes more viscous 
dispersion, leading to the formation of larger emulsion droplet and 
consequently larger particles. The viscous forces oppose the shear 
stresses in the organic phase, and the final particle size depends on 
the net shear stress available for droplet breakdown [21]. A critical 
parameter determining the particle size is diffusion of the organic 
solvent through the interface of emulsion droplet. For shorter 
evaporation time, the diffusion may not have been completed before 
the droplets start to harden, thus forming larger particles. But when 
the organic solvent is allowed to evaporate for a long time, the 
extent of diffusion will be greater, resulting in a smaller particle size. 
An increase in the particle size was observed with increased 
organic/aqueous phase ratio which may be explained by the change 
in viscosity of the emulsion formed during the process. Increased 
viscosity resulted in high viscous resistance against the sheer force 
during the microparticle formation. The external energy (in the form 
of stirring speed and amount of emulsifier) for droplet breakdown 
was kept constant. Thus, on increasing the aqueous phase volume, 
the same amount of energy must be distributed in large volume, 
causing less droplet breakdown and resulting larger particles. When 
the stirring rate was increased from 800 to 1500 rpm, the particle 
size was reduced rapidly (176.25-38.5 µm). This is because higher 
energy is released in the process that leads to the rapid breakdown 
of the emulsion droplets, resulting in smaller particle size [19]. The 
particle size distribution of the optimized formulation was shown in 
fig. 2. 
 
Table 3: Comparison of entrapment efficiency, particle size and the cumulative amount of drug release from extract-loaded ethyl cellulose 
microspheres prepared using various process and formulation variables 
Batch code Entrapment efficiency(%±SD) Mean particle size (µm±SD) Cumulative drug release at 12h (%±SD) 
F1 39.03±2.6 176.25±58.4 62.30±1.2 
F2 30.03±2.1 45.5±26.4 88.30±0.8 
F3 19.52±1.9 38.5±20.8 92.50±1.6 
F4 15.01±3.6 128.95±43.1 61.20±2.1 
F5 25.52±2.9 87.5±35.1 72.47±1.1 
F6 30.03±2.1 45.5±26.4 88.30±0.8 
F7 18.00±4.3 34.5±23.7 99.22±1.8* 
F8 30.03±2.1 45.5±26.4 88.30±0.8 
F9 42.00±1.9 114.75±45.9 56.19±2.0 
F10 30.03±2.1 45.5±26.4 88.30±0.8 
F11 24.02±3.2 73.25±41.6 73.00±1.7 
F12 10.51±3.9 113.25±43.4 68.57±2.1 
Data represent mean±standard deviation (SD), n=3. For particle size n=100. *CDR at 8 h. 
 
 
Fig. 1: Effect of (a) Stirring speed, (b) Evaporation time, (c) Drug/polymer ratio and (d) Aqueous/organic phase ratio on the particle size 
of the extract-loaded ethyl cellulose microspheres (data represent mean±SD, where n=3). SD = standard deviation 
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Fig. 2: Particle size distribution of the optimized formulation 
 
In vitro drug release study 
In vitro drug release from extract-loaded ethyl cellulose 
microspheres was investigated both in gastric (pH 1.2) and 
intestinal (pH 7.4) pH. Dissolution studies were performed for 2 h at 
pH 1.2 and 12 h at pH 7.4. At pH 1.2 negligible amount of drug was 
released from all the formulations (<8%). Whereas at pH 7.4 the 
maximum drug release (56.19-99.22%) indicating the sustained 
release pattern of the drug from microspheres. The cumulative 
amount of drug released (CDR) at 12 h from formulation F7-F9 with 
drug-polymer ratio 1:1, 1:2 and 1:3 were 99.22%, 88.3%, and 
56.19% respectively. The decreased % CDR could be due to the 
increased particle size, resulting in the smaller surface area at high 
polymer concentration. Another explanation could be the high 
polymer concentration hinders the drug release by diffusion. 
Evaporation time influences the particle size and hence affects the 
drug release. Greater drug release was observed from the 
formulation F6, prepared with longer evaporation time (3h), due to 
smaller particle size. Rapid solvent evaporation leads to the 
smoother surface of the particles as compared to the particles 
obtained by delayed solvent evaporation. Thus the smoother surface 
of the particles resulted in the much slower release. Smaller 
particles were obtained at a high, stirring rate as high speed causes 
the formation of the finer dispersion of the microparticles. It was 
explained previously that smaller the particle size, greater the 
surface area, resulting in faster drug release. Maximum release 
(92.5%) was observed at the speed of 1500 rpm, but at 800 rpm that 
was 62.30% due to the formation of larger particles. Larger the 
particles, slower the drug release because of longer diffusion 
pathways that the drug had to travel to reach dissolution medium. 
The CDR at 12 h decreased with increasing aqueous phase volume 
used in the preparation of microspheres. The difference in release 
profiles can be attributed to the difference in the surface of the 
microparticles regardless of the difference in their size. The large 
volume of aqueous phase causes faster precipitation of the polymer, 
resulting in the formation of smoother and less porous surface of 
microparticles. Porosity increases with decreasing aqueous phase 
volume and thus lower organic/aqueous phase ratio resulted in a 
more porous surface leading to faster drug release [13, 19]. The CDR 
at 12 h from F10 to F12 prepared with organic/aqueous phase ratio 
1:3, 1:5 and 1:10 were 88.3%, 73%, and 68.57% respectively. 
 
 
Fig. 3: Effect of (a) Stirring speed, (b) Evaporation time, (c) Drug/polymer ratio and (d) Aqueous/organic phase ratio on in vitro drug 
release of the extract-loaded ethyl cellulose microspheres (data represent mean±SD, where n=3). SD = standard deviation 
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Fig. 4: In vitro drug release profile of optimized formulation (data represent mean±SD, where n=3). SD = standard deviation 
 
Release kinetics study 
The dissolution data of the optimized formulation was analyzed 
according to various model dependent approaches (zero order, 
first order, Higuchi, and Korsmeyer-Peppas) and the mode of drug 
release from microspheres was calculated by plotting the curves. 
The kinetic model with the highest value of the coefficient of 
determination (R2) was considered to be a more suitable model 
for dissolution profile. In vitro release data follows first-order 
kinetics (R2=0.988) followed by Higuchi model (R2=0.978). 
Release mechanism was studied by Peppas equation. The value of 
slope (n) was calculated and found to be greater than 0.89 which 
indicates the mode of drug release is super case II type in which 
the erosion of the polymer takes place to release the drug content 
from the matrix. The first order plot of optimized formulation was 
shown in fig. 5. 
 
 
Fig. 5: First order plot of optimized formulation 
 
 
Fig. 6: FTIR spectra of (a) Extract, (b) Polymer (EC), (c) Empty microspheres and (d) Extract-loaded microspheres 
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Compatibility study by FTIR spectroscopy 
The compatibility of the extract with the excipients in this 
formulation was evaluated qualitatively through FTIR analysis. The 
FTIR spectra obtained for pure extract, polymer, empty 
microspheres and extract-loaded microspheres, could confirm the 
chemical compatibility of extract in the ethyl cellulose microspheres. 
The FTIR spectrum of Syzygium cumini seed extract exhibited 
absorption in the range of 3404.66 cm-1 to 637.11 cm-1 (fig. 6). The 
spectrum showed a broad brand around 3404.66 cm-1 assigned to 
alcohol and hydroxyl group (OH) stretching, which also indicated 
the presence of phenol and flavonoid. The sharp peak observed at 
2929.14 cm-1 indicates the presence of alkane group (C-H). Another 
sharp peak at 1623.08 cm-1 associated with an N-H stretching 
(primary amines). The peaks at 1451.87 and 1363.00 cm-1 
represent CH stretching. The sharp peak observed at 1047.98 cm-1 
indicates the presence of aliphatic amines (C-N). The peaks observed 
at 921.01, 773.66 and 637.11 cm-1 represents C-H stretching [5]. 
The characteristic peaks of the extract indicate no major shift of the 
peak positions, matching the extract-loaded formulation spectrum. 
Thus the spectral analysis showed that the extract is stable in the 
ethyl cellulose microspheres. 
Surface morphology 
The SEM photograph indicates that the prepared ethyl cellulose 
microspheres were spherical in shape with a smooth and dense 
outer surface (fig. 7) without any aggregation. Distinct pores were 
evident on the surface of microspheres, which will be responsible 
for drug release. 
  
 
Fig. 7: SEM photographs of EC microspheres: (a) F1, (b) F2 
 
DSC analysis 
DSC studies were performed to understand the nature and interaction 
of the encapsulated drug in the matrix. The physical state of the drug 
in the polymer matrix would also influence its release characteristics 
[12]. DSC analysis was performed on extract, extract-loaded 
microspheres and the respective thermograms are shown in fig. The 
extract showed a characteristic peak at 259 °C, which represents the 
melting point of Gallic acid, but the same was not found in the 
thermogram of the formulation. A similar observation has been 
reported by [8]. These results suggested that the extract was dispersed 
throughout the polymer forming a high energy amorphous state. 
 
 
Fig. 8: DSC thermogram of the extract 
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Fig. 9: DSC thermogram of the microspheres 
 
XRD analysis 
X-RD of extract and extract-loaded microspheres were carried out 
by using X-Ray Diffractometer to find out any change in the 
crystallinity of drug during microencapsulation. The x-ray 
diffractogram of extract showed sharp peaks, whereas the 
formulation decreased the sharpness of peak which indicated that 
the polymer dispersed the extract at molecular level blended ethyl 
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Fig. 11: X-ray diffraction spectra of the microspheres 
 
CONCLUSION 
Extensive work on the formulation and characterization of extract-
loaded EC microspheres was evaluated. The development of 
formulation and optimization yields the desired microspheres with 
sustained drug release for 12 h. the rheological properties exhibited 
that all microspheres were free-flowing in nature. SEM photographs 
confirmed the spherical shape of the microspheres. The results of 
FTIR, DSC, and XRD revealed that experimental conditions allowed a 
uniform distribution of the extract within EC microspheres having 
no significant effect on drug-polymer interaction. The particle size 
was found to be in the range of 34.25–176.25 µm and showed 
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uniform size distribution. Finally, the results of this investigation 
elucidate that the process and formulation variables could be 
effectively altered to achieve the desired characteristics of the EC 
microspheres for novel delivery of the herbal drug. 
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